INDIANAPOLIS – (2024 年 4 月 30 日) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications. The partnership harnesses the value of each organization to deliver robust and reliable automated liquid handling solutions that enable labs to streamline operations and generate consistent results.
As part of the agreement, the two companies will co-develop methods for NGS library preparation leveraging Watchmaker’s portfolio of rapid and highly sensitive DNA and RNA solutions on the Biomek i7 Dual Hybrid Liquid Handler from Beckman Coulter Life Sciences. The tip-based automated liquid handler offers a complete walkaway solution that is flexible and versatile, allowing a variety of sample sizes, reagent volumes, labware, device integrations, and supplemental steps to transform laboratory workflows.
“The genomics field requires innovative tools that address bottlenecks in both workflow and sensitivity while also delivering robust performance with highly challenging sample types,” said Kerri Stellato, Chief Commercial Officer at Watchmaker Genomics. “This collaboration will deliver solutions that check all of those boxes – ultimately saving users time and operational bandwidth while improving data quality.”
With the global NGS market projected to grow to nearly $27 billion by 2027, demand is expected to increase for solutions to provide critical assistance to NGS labs.
“As more labs around the world tap into next generation sequencing, we’re ready to help by delivering innovative solutions to reduce complexities and turnaround time while improving accuracy,” said Elsa Burgess, Vice President and General Manager of Biotech Workflow Solutions at Beckman Coulter Life Sciences. “This partnership fuels our mission to help labs of all sizes harness the benefits of automation to accelerate pioneering research discoveries, whether for NGS needs, sample management, drug discovery, functional screening, synthetic biology, or proteomics.”
One of the first outputs of this collaboration will be an RNA library preparation method that enables walkaway, automated processing of up to 96 libraries in under 8 hours. The method will use the Watchmaker RNA Library Prep Kit with Polaris Depletion and support clinically relevant samples, including formalin-fixed, paraffin-embedded (FFPE) samples, as well as input amounts as low as 1 ng.
About Beckman Coulter Life Sciences
With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs approximately 2,800 associates with more than 400,000 systems installed globally. Get to know us by clicking here and by following us on 扫描下方二维码。
关于Watchmaker Genomics
Watchmaker Genomics（沃奇酶科）运用先进的酶学技术，实现各种DNA和RNA读取、写入和编辑方面的突破性应用。该公司将蛋白质工程领域的专长与大规模酶制造技术相结合，以满足高速增长的临床基因组学应用市场对产品质量、性能和生产规模方面的严苛要求。Watchmaker 的产品线包括新一代测序、合成生物学及分子诊断应用所需的精准酶及成套试剂盒。更多信息，请访问其官网 www.watchmakergenomics.com 或 扫描下方二维码。
Media Contacts:
Jen Pavlica
Sr. Product Manager, Strategic
Watchmaker Genomics
jen.pavlica@watchmakergenomics.com
